Acyl hydrazides as kinase inhibitors, in particular for sgk

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 243/40 (2006.01) A61K 31/166 (2006.01) A61P 3/00 (2006.01) C07C 243/38 (2006.01) C07C 255/57 (2006.01) C07C 323/62 (2006.01)

Patent

CA 2603475

Novel acyl hydrazides of the formula (I), in which R1 - R9 have the meanings defined in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertension, cardiovascular diseases and kidney diseases, and generally any types of fibroses and inflammatory processes.

L'invention concerne de nouveaux acylhydrazides de formule (I) dans laquelle R1 - R9 ont la signification indiquée dans la revendication 1. Ces nouveaux acylhydrazides constituent des inhibiteurs de la SGK et peuvent être utilisés pour le traitement de maladies liées à la SGK ainsi que des affections telles que le diabète, l'adiposité, le syndrome métabolique (dyslipidémie), l'hypertonie généralisée et pulmonaire, les maladies cardio-vasculaires et les maladies rénales, ainsi qu'en général tout type de fibroses et de processus inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acyl hydrazides as kinase inhibitors, in particular for sgk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acyl hydrazides as kinase inhibitors, in particular for sgk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl hydrazides as kinase inhibitors, in particular for sgk will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1614982

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.